Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions

Akihito Tanaka, RJ Jabbour, S Mitomo, A Latib, A Colombo

Research output: Contribution to journalArticlepeer-review

Abstract

Bioresorbable vascular scaffolds (BVS) have become an attractive option in the percutaneous coronary intervention field due to the potential advantages associated with the complete resorption process that occurs within a few years. However, current-generation BVS have several limitations including thicker struts, reduced radial strength, and limited expansion capability when compared with drug-eluting stents (DES). As a result, complex coronary disease often contains BVS-inappropriate/unfavorable segments. This does not necessarily mean that BVS use must be completely avoided, and minimizing the length of permanent metallic caging may still be advantageous. Operators should fully understand the limitations of current BVS, and when to consider a hybrid strategy of BVS in combination with DES or drug-coated balloons. © 2017 American College of Cardiology Foundation
Original languageEnglish
Pages (from-to)539-547
Number of pages9
JournalJACC: Cardiovascular Interventions
Volume10
Issue number6
DOIs
Publication statusPublished - 2017

Fingerprint

Dive into the research topics of 'Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions'. Together they form a unique fingerprint.

Cite this